Industry Research Reports

Home > Reports > Pharma & Healthcare > Diabetes Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Diabetes Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-05-17

Pages: 144 Pages

Report ld: 2657362

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global market for Diabetes Medicines was estimated to be worth US$ 97410 million in 2023 and is forecast to a readjusted size of US$ 207020 million by 2030 with a CAGR of 11.2% during the forecast period 2024-2030.

Diabetes Medicines Market Size

M= millions and B=billions

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%. 
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

This report aims to provide a comprehensive presentation of the global market for Diabetes Medicines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Medicines by region & country, by Type, and by Application.

The Diabetes Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Medicines.

Market Segmentation

Report Metric
Details
Report Title
Diabetes Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 207020 million
CAGR(2024-2030)
11.2%
Market Size Available for Years
2019-2030
Global Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Medicines Market, Segment by Type
Oral

Injection
Global Diabetes Medicines Market, Segment by Application
Hospital

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetes Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diabetes Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diabetes Medicines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Diabetes Medicines Product Introduction
    1.2 Global Diabetes Medicines Market Size Forecast
        1.2.1 Global Diabetes Medicines Sales Value (2019-2030)
        1.2.2 Global Diabetes Medicines Sales Volume (2019-2030)
        1.2.3 Global Diabetes Medicines Sales Price (2019-2030)
    1.3 Diabetes Medicines Market Trends & Drivers
        1.3.1 Diabetes Medicines Industry Trends
        1.3.2 Diabetes Medicines Market Drivers & Opportunity
        1.3.3 Diabetes Medicines Market Challenges
        1.3.4 Diabetes Medicines Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Diabetes Medicines Players Revenue Ranking (2023)
    2.2 Global Diabetes Medicines Revenue by Company (2019-2024)
    2.3 Global Diabetes Medicines Players Sales Volume Ranking (2023)
    2.4 Global Diabetes Medicines Sales Volume by Company Players (2019-2024)
    2.5 Global Diabetes Medicines Average Price by Company (2019-2024)
    2.6 Key Manufacturers Diabetes Medicines Manufacturing Base and Headquarters
    2.7 Key Manufacturers Diabetes Medicines Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Diabetes Medicines
    2.9 Diabetes Medicines Market Competitive Analysis
        2.9.1 Diabetes Medicines Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Diabetes Medicines Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral
        3.1.2 Injection
    3.2 Global Diabetes Medicines Sales Value by Type
        3.2.1 Global Diabetes Medicines Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Diabetes Medicines Sales Value, by Type (2019-2030)
        3.2.3 Global Diabetes Medicines Sales Value, by Type (%) (2019-2030)
    3.3 Global Diabetes Medicines Sales Volume by Type
        3.3.1 Global Diabetes Medicines Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Diabetes Medicines Sales Volume, by Type (2019-2030)
        3.3.3 Global Diabetes Medicines Sales Volume, by Type (%) (2019-2030)
    3.4 Global Diabetes Medicines Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Retail Pharmacy
    4.2 Global Diabetes Medicines Sales Value by Application
        4.2.1 Global Diabetes Medicines Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Diabetes Medicines Sales Value, by Application (2019-2030)
        4.2.3 Global Diabetes Medicines Sales Value, by Application (%) (2019-2030)
    4.3 Global Diabetes Medicines Sales Volume by Application
        4.3.1 Global Diabetes Medicines Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Diabetes Medicines Sales Volume, by Application (2019-2030)
        4.3.3 Global Diabetes Medicines Sales Volume, by Application (%) (2019-2030)
    4.4 Global Diabetes Medicines Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Diabetes Medicines Sales Value by Region
        5.1.1 Global Diabetes Medicines Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Diabetes Medicines Sales Value by Region (2019-2024)
        5.1.3 Global Diabetes Medicines Sales Value by Region (2025-2030)
        5.1.4 Global Diabetes Medicines Sales Value by Region (%), (2019-2030)
    5.2 Global Diabetes Medicines Sales Volume by Region
        5.2.1 Global Diabetes Medicines Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Diabetes Medicines Sales Volume by Region (2019-2024)
        5.2.3 Global Diabetes Medicines Sales Volume by Region (2025-2030)
        5.2.4 Global Diabetes Medicines Sales Volume by Region (%), (2019-2030)
    5.3 Global Diabetes Medicines Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Diabetes Medicines Sales Value, 2019-2030
        5.4.2 North America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Diabetes Medicines Sales Value, 2019-2030
        5.5.2 Europe Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Diabetes Medicines Sales Value, 2019-2030
        5.6.2 Asia Pacific Diabetes Medicines Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Diabetes Medicines Sales Value, 2019-2030
        5.7.2 South America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Diabetes Medicines Sales Value, 2019-2030
        5.8.2 Middle East & Africa Diabetes Medicines Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Diabetes Medicines Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Diabetes Medicines Sales Value
        6.2.1 Key Countries/Regions Diabetes Medicines Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Diabetes Medicines Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Diabetes Medicines Sales Value, 2019-2030
        6.3.2 United States Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Diabetes Medicines Sales Value, 2019-2030
        6.4.2 Europe Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Diabetes Medicines Sales Value, 2019-2030
        6.5.2 China Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Diabetes Medicines Sales Value, 2019-2030
        6.6.2 Japan Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Diabetes Medicines Sales Value, 2019-2030
        6.7.2 South Korea Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Diabetes Medicines Sales Value, 2019-2030
        6.8.2 Southeast Asia Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Diabetes Medicines Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Diabetes Medicines Sales Value, 2019-2030
        6.9.2 India Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Diabetes Medicines Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Company Information
        7.1.2 Novo Nordisk Introduction and Business Overview
        7.1.3 Novo Nordisk Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Novo Nordisk Diabetes Medicines Product Offerings
        7.1.5 Novo Nordisk Recent Development
    7.2 Sanofi
        7.2.1 Sanofi Company Information
        7.2.2 Sanofi Introduction and Business Overview
        7.2.3 Sanofi Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Sanofi Diabetes Medicines Product Offerings
        7.2.5 Sanofi Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Company Information
        7.3.2 Eli Lilly Introduction and Business Overview
        7.3.3 Eli Lilly Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Eli Lilly Diabetes Medicines Product Offerings
        7.3.5 Eli Lilly Recent Development
    7.4 Merck
        7.4.1 Merck Company Information
        7.4.2 Merck Introduction and Business Overview
        7.4.3 Merck Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Merck Diabetes Medicines Product Offerings
        7.4.5 Merck Recent Development
    7.5 AstraZeneca
        7.5.1 AstraZeneca Company Information
        7.5.2 AstraZeneca Introduction and Business Overview
        7.5.3 AstraZeneca Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 AstraZeneca Diabetes Medicines Product Offerings
        7.5.5 AstraZeneca Recent Development
    7.6 bayer
        7.6.1 bayer Company Information
        7.6.2 bayer Introduction and Business Overview
        7.6.3 bayer Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 bayer Diabetes Medicines Product Offerings
        7.6.5 bayer Recent Development
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Company Information
        7.7.2 Boehringer Ingelheim Introduction and Business Overview
        7.7.3 Boehringer Ingelheim Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.7.4 Boehringer Ingelheim Diabetes Medicines Product Offerings
        7.7.5 Boehringer Ingelheim Recent Development
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Company Information
        7.8.2 Johnson & Johnson Introduction and Business Overview
        7.8.3 Johnson & Johnson Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.8.4 Johnson & Johnson Diabetes Medicines Product Offerings
        7.8.5 Johnson & Johnson Recent Development
    7.9 Takeda
        7.9.1 Takeda Company Information
        7.9.2 Takeda Introduction and Business Overview
        7.9.3 Takeda Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.9.4 Takeda Diabetes Medicines Product Offerings
        7.9.5 Takeda Recent Development
    7.10 Tonghua Dongbao
        7.10.1 Tonghua Dongbao Company Information
        7.10.2 Tonghua Dongbao Introduction and Business Overview
        7.10.3 Tonghua Dongbao Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.10.4 Tonghua Dongbao Diabetes Medicines Product Offerings
        7.10.5 Tonghua Dongbao Recent Development
    7.11 United Pharmaceuticals
        7.11.1 United Pharmaceuticals Company Information
        7.11.2 United Pharmaceuticals Introduction and Business Overview
        7.11.3 United Pharmaceuticals Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.11.4 United Pharmaceuticals Diabetes Medicines Product Offerings
        7.11.5 United Pharmaceuticals Recent Development
    7.12 Ganli Pharmaceutical
        7.12.1 Ganli Pharmaceutical Company Information
        7.12.2 Ganli Pharmaceutical Introduction and Business Overview
        7.12.3 Ganli Pharmaceutical Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.12.4 Ganli Pharmaceutical Diabetes Medicines Product Offerings
        7.12.5 Ganli Pharmaceutical Recent Development
    7.13 Biocon
        7.13.1 Biocon Company Information
        7.13.2 Biocon Introduction and Business Overview
        7.13.3 Biocon Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.13.4 Biocon Diabetes Medicines Product Offerings
        7.13.5 Biocon Recent Development
    7.14 Conker Pharmaceuticals
        7.14.1 Conker Pharmaceuticals Company Information
        7.14.2 Conker Pharmaceuticals Introduction and Business Overview
        7.14.3 Conker Pharmaceuticals Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.14.4 Conker Pharmaceuticals Diabetes Medicines Product Offerings
        7.14.5 Conker Pharmaceuticals Recent Development
    7.15 Jiangsu Wanbang
        7.15.1 Jiangsu Wanbang Company Information
        7.15.2 Jiangsu Wanbang Introduction and Business Overview
        7.15.3 Jiangsu Wanbang Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.15.4 Jiangsu Wanbang Diabetes Medicines Product Offerings
        7.15.5 Jiangsu Wanbang Recent Development
    7.16 Geropharm
        7.16.1 Geropharm Company Information
        7.16.2 Geropharm Introduction and Business Overview
        7.16.3 Geropharm Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.16.4 Geropharm Diabetes Medicines Product Offerings
        7.16.5 Geropharm Recent Development
    7.17 Wockhardt
        7.17.1 Wockhardt Company Information
        7.17.2 Wockhardt Introduction and Business Overview
        7.17.3 Wockhardt Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.17.4 Wockhardt Diabetes Medicines Product Offerings
        7.17.5 Wockhardt Recent Development
    7.18 Merck Serono
        7.18.1 Merck Serono Company Information
        7.18.2 Merck Serono Introduction and Business Overview
        7.18.3 Merck Serono Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.18.4 Merck Serono Diabetes Medicines Product Offerings
        7.18.5 Merck Serono Recent Development
    7.19 Novartis
        7.19.1 Novartis Company Information
        7.19.2 Novartis Introduction and Business Overview
        7.19.3 Novartis Diabetes Medicines Sales, Revenue, Price and Gross Margin (2019-2024)
        7.19.4 Novartis Diabetes Medicines Product Offerings
        7.19.5 Novartis Recent Development

 8 Industry Chain Analysis
    8.1 Diabetes Medicines Industrial Chain
    8.2 Diabetes Medicines Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Diabetes Medicines Sales Model
        8.5.2 Sales Channel
        8.5.3 Diabetes Medicines Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Diabetes Medicines Market Trends
 Table 2. Diabetes Medicines Market Drivers & Opportunity
 Table 3. Diabetes Medicines Market Challenges
 Table 4. Diabetes Medicines Market Restraints
 Table 5. Global Diabetes Medicines Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Diabetes Medicines Revenue Market Share by Company (2019-2024)
 Table 7. Global Diabetes Medicines Sales Volume by Company (2019-2024) & (K Units)
 Table 8. Global Diabetes Medicines Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market Diabetes Medicines Price by Company (2019-2024) & (US$/Unit)
 Table 10. Key Manufacturers Diabetes Medicines Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Diabetes Medicines Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Diabetes Medicines
 Table 13. Global Diabetes Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diabetes Medicines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Diabetes Medicines Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global Diabetes Medicines Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global Diabetes Medicines Sales Market Share in Value by Type (2019-2024)
 Table 20. Global Diabetes Medicines Sales Market Share in Value by Type (2025-2030)
 Table 21. Global Diabetes Medicines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
 Table 22. Global Diabetes Medicines Sales Volume by Type (2019-2024) & (K Units)
 Table 23. Global Diabetes Medicines Sales Volume by Type (2025-2030) & (K Units)
 Table 24. Global Diabetes Medicines Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global Diabetes Medicines Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global Diabetes Medicines Price by Type (2019-2024) & (US$/Unit)
 Table 27. Global Diabetes Medicines Price by Type (2025-2030) & (US$/Unit)
 Table 28. Global Diabetes Medicines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global Diabetes Medicines Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global Diabetes Medicines Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global Diabetes Medicines Sales Market Share in Value by Application (2019-2024)
 Table 32. Global Diabetes Medicines Sales Market Share in Value by Application (2025-2030)
 Table 33. Global Diabetes Medicines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
 Table 34. Global Diabetes Medicines Sales Volume by Application (2019-2024) & (K Units)
 Table 35. Global Diabetes Medicines Sales Volume by Application (2025-2030) & (K Units)
 Table 36. Global Diabetes Medicines Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global Diabetes Medicines Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global Diabetes Medicines Price by Application (2019-2024) & (US$/Unit)
 Table 39. Global Diabetes Medicines Price by Application (2025-2030) & (US$/Unit)
 Table 40. Global Diabetes Medicines Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global Diabetes Medicines Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global Diabetes Medicines Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global Diabetes Medicines Sales Value by Region (2019-2024) & (%)
 Table 44. Global Diabetes Medicines Sales Value by Region (2025-2030) & (%)
 Table 45. Global Diabetes Medicines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
 Table 46. Global Diabetes Medicines Sales Volume by Region (2019-2024) & (K Units)
 Table 47. Global Diabetes Medicines Sales Volume by Region (2025-2030) & (K Units)
 Table 48. Global Diabetes Medicines Sales Volume by Region (2019-2024) & (%)
 Table 49. Global Diabetes Medicines Sales Volume by Region (2025-2030) & (%)
 Table 50. Global Diabetes Medicines Average Price by Region (2019-2024) & (US$/Unit)
 Table 51. Global Diabetes Medicines Average Price by Region (2025-2030) & (US$/Unit)
 Table 52. Key Countries/Regions Diabetes Medicines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions Diabetes Medicines Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions Diabetes Medicines Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions Diabetes Medicines Sales Volume, (2019-2024) & (K Units)
 Table 56. Key Countries/Regions Diabetes Medicines Sales Volume, (2025-2030) & (K Units)
 Table 57. Novo Nordisk Company Information
 Table 58. Novo Nordisk Introduction and Business Overview
 Table 59. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 60. Novo Nordisk Diabetes Medicines Product Offerings
 Table 61. Novo Nordisk Recent Development
 Table 62. Sanofi Company Information
 Table 63. Sanofi Introduction and Business Overview
 Table 64. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 65. Sanofi Diabetes Medicines Product Offerings
 Table 66. Sanofi Recent Development
 Table 67. Eli Lilly Company Information
 Table 68. Eli Lilly Introduction and Business Overview
 Table 69. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 70. Eli Lilly Diabetes Medicines Product Offerings
 Table 71. Eli Lilly Recent Development
 Table 72. Merck Company Information
 Table 73. Merck Introduction and Business Overview
 Table 74. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. Merck Diabetes Medicines Product Offerings
 Table 76. Merck Recent Development
 Table 77. AstraZeneca Company Information
 Table 78. AstraZeneca Introduction and Business Overview
 Table 79. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. AstraZeneca Diabetes Medicines Product Offerings
 Table 81. AstraZeneca Recent Development
 Table 82. bayer Company Information
 Table 83. bayer Introduction and Business Overview
 Table 84. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. bayer Diabetes Medicines Product Offerings
 Table 86. bayer Recent Development
 Table 87. Boehringer Ingelheim Company Information
 Table 88. Boehringer Ingelheim Introduction and Business Overview
 Table 89. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Boehringer Ingelheim Diabetes Medicines Product Offerings
 Table 91. Boehringer Ingelheim Recent Development
 Table 92. Johnson & Johnson Company Information
 Table 93. Johnson & Johnson Introduction and Business Overview
 Table 94. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. Johnson & Johnson Diabetes Medicines Product Offerings
 Table 96. Johnson & Johnson Recent Development
 Table 97. Takeda Company Information
 Table 98. Takeda Introduction and Business Overview
 Table 99. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. Takeda Diabetes Medicines Product Offerings
 Table 101. Takeda Recent Development
 Table 102. Tonghua Dongbao Company Information
 Table 103. Tonghua Dongbao Introduction and Business Overview
 Table 104. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. Tonghua Dongbao Diabetes Medicines Product Offerings
 Table 106. Tonghua Dongbao Recent Development
 Table 107. United Pharmaceuticals Company Information
 Table 108. United Pharmaceuticals Introduction and Business Overview
 Table 109. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. United Pharmaceuticals Diabetes Medicines Product Offerings
 Table 111. United Pharmaceuticals Recent Development
 Table 112. Ganli Pharmaceutical Company Information
 Table 113. Ganli Pharmaceutical Introduction and Business Overview
 Table 114. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Ganli Pharmaceutical Diabetes Medicines Product Offerings
 Table 116. Ganli Pharmaceutical Recent Development
 Table 117. Biocon Company Information
 Table 118. Biocon Introduction and Business Overview
 Table 119. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Biocon Diabetes Medicines Product Offerings
 Table 121. Biocon Recent Development
 Table 122. Conker Pharmaceuticals Company Information
 Table 123. Conker Pharmaceuticals Introduction and Business Overview
 Table 124. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Conker Pharmaceuticals Diabetes Medicines Product Offerings
 Table 126. Conker Pharmaceuticals Recent Development
 Table 127. Jiangsu Wanbang Company Information
 Table 128. Jiangsu Wanbang Introduction and Business Overview
 Table 129. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. Jiangsu Wanbang Diabetes Medicines Product Offerings
 Table 131. Jiangsu Wanbang Recent Development
 Table 132. Geropharm Company Information
 Table 133. Geropharm Introduction and Business Overview
 Table 134. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Geropharm Diabetes Medicines Product Offerings
 Table 136. Geropharm Recent Development
 Table 137. Wockhardt Company Information
 Table 138. Wockhardt Introduction and Business Overview
 Table 139. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. Wockhardt Diabetes Medicines Product Offerings
 Table 141. Wockhardt Recent Development
 Table 142. Merck Serono Company Information
 Table 143. Merck Serono Introduction and Business Overview
 Table 144. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. Merck Serono Diabetes Medicines Product Offerings
 Table 146. Merck Serono Recent Development
 Table 147. Novartis Company Information
 Table 148. Novartis Introduction and Business Overview
 Table 149. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 150. Novartis Diabetes Medicines Product Offerings
 Table 151. Novartis Recent Development
 Table 152. Key Raw Materials Lists
 Table 153. Raw Materials Key Suppliers Lists
 Table 154. Diabetes Medicines Downstream Customers
 Table 155. Diabetes Medicines Distributors List
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources


List of Figures
 Figure 1. Diabetes Medicines Product Picture
 Figure 2. Global Diabetes Medicines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global Diabetes Medicines Sales Volume (2019-2030) & (K Units)
 Figure 5. Global Diabetes Medicines Sales Price (2019-2030) & (US$/Unit)
 Figure 6. Diabetes Medicines Report Years Considered
 Figure 7. Global Diabetes Medicines Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global Diabetes Medicines Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Medicines Revenue in 2023
 Figure 10. Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. Oral Picture
 Figure 12. Injection Picture
 Figure 13. Global Diabetes Medicines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 14. Global Diabetes Medicines Sales Value Market Share by Type, 2023 & 2030
 Figure 15. Global Diabetes Medicines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
 Figure 16. Global Diabetes Medicines Sales Volume Market Share by Type, 2023 & 2030
 Figure 17. Global Diabetes Medicines Price by Type (2019-2030) & (US$/Unit)
 Figure 18. Product Picture of Hospital
 Figure 19. Product Picture of Retail Pharmacy
 Figure 20. Global Diabetes Medicines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 21. Global Diabetes Medicines Sales Value Market Share by Application, 2023 & 2030
 Figure 22. Global Diabetes Medicines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
 Figure 23. Global Diabetes Medicines Sales Volume Market Share by Application, 2023 & 2030
 Figure 24. Global Diabetes Medicines Price by Application (2019-2030) & (US$/Unit)
 Figure 25. North America Diabetes Medicines Sales Value (2019-2030) & (US$ Million)
 Figure 26. North America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
 Figure 27. Europe Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 28. Europe Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
 Figure 29. Asia Pacific Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 30. Asia Pacific Diabetes Medicines Sales Value by Region (%), 2023 VS 2030
 Figure 31. South America Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 32. South America Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
 Figure 33. Middle East & Africa Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 34. Middle East & Africa Diabetes Medicines Sales Value by Country (%), 2023 VS 2030
 Figure 35. Key Countries/Regions Diabetes Medicines Sales Value (%), (2019-2030)
 Figure 36. Key Countries/Regions Diabetes Medicines Sales Volume (%), (2019-2030)
 Figure 37. United States Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 38. United States Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 39. United States Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 40. Europe Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 41. Europe Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 42. Europe Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 43. China Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 44. China Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 45. China Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 46. Japan Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 47. Japan Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 48. Japan Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 49. South Korea Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 50. South Korea Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 51. South Korea Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 52. Southeast Asia Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 53. Southeast Asia Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 54. Southeast Asia Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 55. India Diabetes Medicines Sales Value, (2019-2030) & (US$ Million)
 Figure 56. India Diabetes Medicines Sales Value by Type (%), 2023 VS 2030
 Figure 57. India Diabetes Medicines Sales Value by Application (%), 2023 VS 2030
 Figure 58. Diabetes Medicines Industrial Chain
 Figure 59. Diabetes Medicines Manufacturing Cost Structure
 Figure 60. Channels of Distribution (Direct Sales, and Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global market for Diabetes Medicines was estimated to be worth US$ 97410 million in 2023 and is forecast to a readjusted size of US$ 207020 million by 2030 with a CAGR of 11.2% during the forecast period 2024-2030.

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%. 
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

This report aims to provide a comprehensive presentation of the global market for Diabetes Medicines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Medicines by region & country, by Type, and by Application.

The Diabetes Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Medicines.

Market Segmentation